
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded oral liquid containing arginine hydrochloride, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing arginine are listed in injection and solution forms, all for intravenous use.
Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
L-arginine is a conditionally essential amino acid and nitric oxide precursor that compounding pharmacies prepare as oral capsules, powders and topical creams by prescription.
L-arginine is an amino acid the body makes on its own and also takes in from fish, meat, poultry, soy, beans and dairy. It is classed as semi-essential because demand can outstrip supply during growth, stress or illness. Its main known job is as the raw material for nitric oxide, a signaling molecule that relaxes and widens blood vessels; arginase also breaks it down into urea and ornithine. The one FDA-approved manufactured product, R-Gene 10 (arginine hydrochloride injection, Pfizer), is indicated as an intravenous diagnostic aid that stimulates the pituitary to release growth hormone; it is not for therapeutic use. Oral arginine is otherwise sold as a dietary supplement. A prescriber might order compounded arginine in an oral strength or form not manufactured, as a topical cream, or combined with other ingredients. Compounded preparations are not FDA-approved and require a prescription.
R-Gene 10 carries no boxed warning, but its label warns in capital letters that pediatric overdose can cause hyperchloremic metabolic acidosis, brain swelling and death, and that anaphylaxis has been reported. Oral arginine can cause stomach upset, headache, palpitations and low blood pressure. It is not recommended after a recent heart attack because one trial found more deaths in the arginine group, and it can worsen asthma or allergies. It can add to blood pressure medicines, nitrates, isoproterenol and sildenafil, lower blood sugar alongside diabetes medicines, raise bleeding risk with anticoagulants or antiplatelets, and raise potassium with potassium-sparing diuretics such as spironolactone. The injection label says it should not be used in pregnancy and that it is unknown whether arginine passes into breast milk, so use caution while nursing; LactMed has no arginine record. If side effects bother you, talk to your prescriber or pharmacist.
Adults synthesize arginine mainly through the intestinal-renal axis from glutamine, glutamate and proline. Oral arginine undergoes substantial presystemic extraction by gut and liver arginases. Labeled indication (R-Gene 10): intravenous pituitary stimulant for growth hormone reserve testing in suspected panhypopituitarism, pituitary dwarfism, acromegaly and gigantism; the label notes false-positive and false-negative rates of roughly a third and a quarter. Prescribers have ordered compounded oral arginine for blood pressure, preeclampsia risk, erectile dysfunction of organic cause and angina, uses summarized by Mayo Clinic; Mayo describes the evidence as preliminary, and a 2026 ESPEN review calls for further clinical studies. Dosing is per prescriber. Monitor blood pressure, potassium in renal or hepatic impairment, glucose in diabetics, and acid-base status with parenteral use. Not a controlled substance.
Shake the bottle if your label says to. Measure each dose with the oral syringe or dosing cup the pharmacy gave you, never a kitchen spoon. Give the liquid slowly into the mouth. Rinse the syringe with water after each use. Call the pharmacy if you are unsure how to measure.
Storage depends on the vehicle. Water-based liquids with a preservative usually carry a USP <795> beyond-use date of up to 35 days; without a preservative they are kept refrigerated for up to 14 days. Oil-based (nonaqueous) oral liquids may carry up to 90 days. Your label states whether to refrigerate and the beyond-use date. Keep out of reach of children and discard after that date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally